Characteristics | All | Reinvestigated | Not reinvestigated | |||
---|---|---|---|---|---|---|
Presumed fibrosis | Fibrosis Confirmed | Fibrosis still suspected | Indeterminate | All reinvestigated | ||
Number of subjects | 209 | 50 | 27 | 28 | 105 | 104 |
Prevalence of fibrosis1 | 209/7,463 (2.8%) | 100/7,463 (1.3%) | 54/7,463 (0.7%) | 56/7,463 (0.8%) | 100/7,463 (1.4%) | 104/7,463 (1.4%) |
Cause of liver disease | ||||||
Non alcoholic fatty liver disease2 | 98 (47%) | 18 (35%) | 10 (40%) | 13 (46%) | 41 (39%) | 57 (55%) |
Alcoholic liver disease3 | 15 (7%) | 4 (8%) | 1 (4%) | 4 (14%) | 9 (9%) | 6 (6%) |
Non alcoholic and alcoholic | 61 (29%) | 22 (42%) | 11 (44%) | 6 (21%) | 39 (37%) | 22 (21%) |
Chronic hepatitis C | 6 (3.5%) | 4 (8%) | 0 | 1 (4%) | 5 (5%) | 1 (1%) |
Chronic hepatitis B | 3 (1.4%) | 1 (2%) | 1 (4%) | 0 | 3 (3%) | 0 (0%) |
Hemochromatosis | 1 (0.5%) | 1 (2%) | 0 | 0 | 1 (1%) | 0 (0%) |
Auto-immune hepatitis | 1 (0.5%) | 0 (0%) | 1 (4%) | 0 | 1 (1%) | 0 (0%) |
No risk factor | 25 (12%) | 2 (4%) | 1 (4%) | 3 (11%) | 7 (7%) | 18 (17%) |
Liver complications | ||||||
Hepatocellular carcinoma | NP | 0 (0%) | 0 | 0 | 0 | NP |
Portal hypertension | NP | 1 (2%) | 0 | 0 | 1 (1%) | NP |
Stage presumed fibrosis | ||||||
Few septa | 128 (61%) | 26 (50%) | 18 (72%) | 22 (79%) | 66 (63%) | 62 (60%) |
Many septa | 56 (27%) | 17 (33%) | 6 (24%) | 5 (18%) | 28 (27%) | 28 (27%) |
Cirrhosis | 25 (12%) | 9 (17%) | 1 (4%) | 1 (3%) | 11 (10%) | 14 (13%) |
Mode of confirmation4 | ||||||
Elastography | NP | 47 (90%) (>= 7.1 kPa) | 27 (100%) (5kPa-7kPa) | 28 (100%) (<5kPa) | 102(95%) | NP |
Biopsy | NP | 3 (5%) | 0 | 1 (4%) | 4 (4%) | NP |
Endoscopy | NP | 1 (2%) | 0 | 0 | 1 (1%) | NP |